Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/17/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Suresh H. Advani

Wrong Dr. Suresh H. Advani?

Leading Oncologist of India

International Oncology Services Pvt. Ltd
International Oncology Services Private Limited
A-41, The Corenthum (Tower A) 2215, Level 2, Sector 62
Noida , Uttar Pradesh 201301
India

Company Description: International Oncology aspires to be a global leader in providing world class cancer care services. Combining unparalleled clinical experience of our physicians,...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Doctorate of Medicine , Medical Oncology
    Tata Memorial Hospital
89 Total References
Web References
Meet Our Team_Mumbai
www.internationaloncology.com, 17 July 2015 [cached]
Dr. Suresh H Advani Dr. Suresh Advani, is a leading oncologist of India with 25 years of experience. Since 1974 he has been involved with Medical Oncology / Hematology with strong interaction with other clinical branches and basic scientists. The pioneer of bone marrow transplant in India, he was awarded the Dhanvantri Award in 2002 and the Padmashri in 2003 for his contribution in the field of scientific research in medical oncology.
Venues of Indo-Global Healthcare Summit & Expo 2014
www.indus.org, 3 Feb 2015 [cached]
Dr. Suresh H. Advani Medical Oncologist S.L.Raheja Hospital
Dr S H ...
www.navtechmedicare.com, 4 Jan 2014 [cached]
Dr S H Advani, Medical Oncology
A former chief of medical oncology at the Tata Memorial Hospital, Dr Advani helped set up the oncology department at Jaslok. Today, he is the chief medical and paediatric oncologist and heamato oncologist at Jaslok Hospital. Dr Advani received the Padma Shri award in 2002.
Padma Vibhushan Dr. S. H ...
spicystarsmumbai.com, 17 Oct 2012 [cached]
Padma Vibhushan Dr. S. H Advani [Director Medical Oncology, Jaslok Hospital] said, "Breast Cancer is seeing an alarming rise in our country.
INCTR: Newsletter
www.inctr.org, 1 Jan 2003 [cached]
Dr Advani confers with Ian Magrath at the INCTR annual meeting.
...
Suresh Advani, the man who pioneered bone marrow treatment for leukemia in India, is one of the most highly-decorated physicians in the country. Last year, in recognition of his significant achievements in medical research and education, he received both the Padmashree Award, a civilian honor for lifetime achievements, and then, in early November, the Dhanvantri Award, India's highest recognition in the field of medicine.
The former Chief of Medical Oncology at Tata Memorial Hospital, Advani also helped to establish the Oncology Department at Jaslok Hospital, Mumbai, where he is now the Chief Oncologist. He is working with the faculty at Mumbai University to standardize the oncology syllabi used in its medical colleges. And he has established the Asian Institute of Oncology at Bombay, providing cancer treatment at affordable cost.
Dr Advani, 56, trained in general medicine and in hematology at JJ Hospital at Grant Medical College in Mumbai, and studied oncology in the United States. He joined the Oncology Department of Tata Memorial Center and Research Institute in 1974. Here, he undertook clinical work along with research in hematology and medical oncology. He devoted the next 28 years to developing a modern oncology center and operating India's most advanced hematology laboratory. He established the first bone marrow transplantation unit in 1983.
Among his research projects were cytogenetic studies in chronic myeloid leukemia (CML) and myeloblastic leukemia (AML); the cytochemistry of leukemias; enzymatic patterns in leukemias; cell-mediated immunity in CML; cell-mediated immunity in Hodgkin's disease and myelomas; and polyamines in Hodgkin's disease. Advani has published more than 500 papers in international medical journals.
Advani began practicing medicine when oncology was an emerging field in India-and when survival rates for acute lymphoblastic leukemia (ALL), for instance, were less than 25%. During the past 15 years, long-term survival rates for ALL have risen to nearly 60% at the Tata Memorial Hospital. Early on, he recognized the importance of international cooperation, particularly for workforce training and the transfer of technology. The success in treating leukemia is due in large part to hospitals across the country adopting uniform procedures for diagnosis and treatment (recorded in a "protocol" document) developed by Advani and his colleagues at other major centers, in collaboration with cancer experts from the National Cancer Institute (now with INCTR).
Advani believes standardization is critical in the fight against cancer. The treatment protocol outlines how specific drugs should be administered, what side effects might be anticipated, and how those side effects should be treated. The ALL protocol calls for drugs in their generic form, which are more cost-effective than new drugs coming to the market.
"Being a cancer institute in a developing country, we have a tremendous responsibility not only to deliver treatment, but also to promote education and research," Advani says.
Other People with the name "Advani":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.